Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | MC4R | P32245 | 1/20 | 0.40 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.40 |
| ▸ | MC3R | P41968 | 1/20 | 0.40 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.39 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.37 |
| ▸ | NAMPT | P43490 | 3/20 | 0.36 |
| ▸ | ABCC9 | O60706 | 1/20 | 0.36 |
| ▸ | ABCC8 | Q09428 | 1/20 | 0.36 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.36 |
| ▸ | KCNJ8 | Q15842 | 1/20 | 0.36 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10716049 | 0.98 | NAPRT (0.42) | NAPRTKDM4EHCAR2ADORA3TSHR | |
| SCHEMBL8155865 | 0.98 | NAPRT (0.42) | NAPRTKDM4EHCAR2ADORA3TSHR | |
| Hydrochloric Acid SCHEMBL27947207 | 0.98 | NAPRT (0.42) | NAPRTKDM4EHCAR2ADORA3TSHR | |
| SCHEMBL7835984 | 0.80 | SLC40A1 (0.41) | NAPRTKDM4EHCAR2ADORA3TSHR | |
| SCHEMBL329658 | 0.78 | SLC40A1 (0.40) | NAPRTKDM4EHCAR2ADORA3TSHR | |
| SCHEMBL11561904 | 0.76 | KDM4E (0.39) | NAPRTKDM4ETSHRALDH1A1SMN1; SMN2 | |
| SCHEMBL1076499 | 0.76 | CA12 (0.43) | NAPRTKDM4EHCAR2ADORA3TSHR | |
| SCHEMBL3155945 | 0.76 | SLC40A1 (0.39) | NAPRTKDM4EHCAR2ADORA3TSHR | |
| SCHEMBL8230218 | 0.76 | SLC40A1 (0.46) | NAPRTKDM4EHCAR2ADORA3TSHR | |
| SCHEMBL10716052 | 0.74 | SLC40A1 (0.38) | NAPRTKDM4EHCAR2ADORA3TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200360562-A1 | ADHESION LAYER BONDED TO AN ACTIVATED SURFACE | THE TRUSTEES OF PRINCETON UNIVERSITY | 2020-11-19 | — | — | US | claimed |
| US-20070009592-A1 | IMMEDIATE RELEASE PHARMACEUTICAL GRANULE COMPOSITIONS AND A CONTINUOUS PROCESS FOR MAKING THEM | UNIVERSITEIT GENT (BE) | 2007-01-11 | — | — | US | claimed |
| EP-4298167-B1 | PROCESS FOR PREPARING AN ANTIMICROBIAL COATING COMPOSITION, ANTIMICROBIAL COATING COMPOSITION AND USE THEREOF TO CONFER ANTIMICROBIAL PROPERTIES TO THE SURFACE OF A SUBSTRATE | ENI SPA (IT) | 2025-10-01 | — | — | EP | disclosed |
| US-20240166896-A1 | PROCESS FOR PREPARING AN ANTIMICROBIAL COATING COMPOSITION, ANTIMICROBIAL COATING COMPOSITION AND USE THEREOF TO CONFER ANTIMICROBIAL PROPERTIES TO THE SURFACE OF A SUBSTRATE | ENI S.P.A. (IT) | 2024-05-23 | — | — | US | disclosed |
| EP-4366733-A1 | TETRAHYDROPYRAZOLOPYRIDINE-ANALOG LIGANDS OF NLRX1 AND USES THEREOF | LANDOS BIOPHARMA, INC. (US) | 2024-05-15 | — | — | EP | disclosed |
| CN-112859523-B | Polyimide positive photoresist composition | 台湾永光化学工业股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-117597361-A | Heterodimeric antibodies and antigen-binding fragments thereof | 成都恩沐生物科技有限公司 | 2024-02-23 | — | — | CN | disclosed |
| EP-3927427-B1 | LANTHIONINE C-LIKE PROTEIN 2 LIGANDS, CELLS PREPARED THEREWITH, AND THERAPIES USING SAME | NIMMUNE BIOPHARMA INC (US) | 2024-02-07 | — | — | EP | disclosed |
| EP-4298167-A1 | PROCESS FOR PREPARING AN ANTIMICROBIAL COATING COMPOSITION, ANTIMICROBIAL COATING COMPOSITION AND USE THEREOF TO CONFER ANTIMICROBIAL PROPERTIES TO THE SURFACE OF A SUBSTRATE | ENI S.p.A. (IT) | 2024-01-03 | — | — | EP | disclosed |
| US-20230357744-A1 | ENGINEERED TRYPTOPHAN DECARBOXYLASES AND USES THEREOF FOR SYNTHESIZING TRYPTAMINE ANALOGS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-11-09 | — | — | US | disclosed |
| CN-116940641-A | Method for producing an antimicrobial coating composition, antimicrobial coating composition and use thereof for imparting antimicrobial properties to a substrate surface | 埃尼股份公司 | 2023-10-24 | — | — | CN | disclosed |
| EP-0358400-B1 | Improvements in or relating to polymeric compounds | DU PONT (US) | 1993-11-10 | — | — | EP | disclosed |
| US-5236966-A | POLYMERIC MATERIALS | BRITISH TECHNOLOGY GROUP LIMITED (GB) | 1993-08-17 | — | — | US | disclosed |
| US-5227276-A | NEGATIVE-WORKING RADIATION-SENSITIVE MIXTURE, AND RADIATION-SENSITIVE RECORDING MATERIAL PRODUCED WITH THIS MIXTURE | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-07-13 | — | — | US | disclosed |
| EP-0489068-A1 | POLYMERIC MATERIALS. | BRITISH TECH GROUP (GB) | 1992-06-10 | — | — | EP | disclosed |
| WO-1991002763-A1 | POLYMERIC MATERIALS | BRITISH TECHNOLOGY GROUP PLC (GB) | 1991-03-07 | — | — | WO | disclosed |
| EP-0358400-A2 | Improvements in or relating to polymeric compounds | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-03-14 | — | — | EP | disclosed |
| EP-0227487-A2 | Positive type radiation-sensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1987-07-01 | — | — | EP | disclosed |
| US-4638005-A | ELECTRON CARRIERS IN THE PHOTOENZYMATIC PRODUCTION OF HYDROGEN AND AMMONIA | THE COCA-COLA COMPANY | 1987-01-20 | — | — | US | disclosed |
| US-4496647-A | Treatment of image-forming laminated plate | TORAY INDUSTRIES, INC. (JP) | 1985-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200360562-A1 | ADHESION LAYER BONDED TO AN ACTIVATED SURFACE | EPCAM, ICAM1, ITGAL | NAPRT 2389/4885KDM4E 3864/4885HCAR2 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.